ERAS
Erasca (ERAS)
$54
About Erasca (ERAS)
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
Details
Daily high
$2.59
Daily low
$2.38
Price at open
$2.43
52 Week High
$3.45
52 Week Low
$1.64
Market cap
718.1M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
1.5M
P/E ratio
-3.06
Erasca News
Details
Daily high
$2.59
Daily low
$2.38
Price at open
$2.43
52 Week High
$3.45
52 Week Low
$1.64
Market cap
718.1M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
1.5M
P/E ratio
-3.06